SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Interim Management Statement

13 Feb 2014 07:00

RNS Number : 9397Z
Oxford Instruments PLC
13 February 2014
 



Release date: 13 February 2014

 

Oxford Instruments plc

Interim Management Statement

 

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues its Interim Management Statement which covers the period from 1 October 2013 to date.

The positive trend seen in the second quarter of the year has continued with orders ahead of the prior year in the four months since September. Year to date, order run rate is ahead of last year in Asia, Europe and North America.

Year to date sales remain behind the same period last year. However we are anticipating a strong February and March and, despite the recent strength of Sterling and continuing underperformance at our Omicron facility in Germany, we are expecting performance for the year to be broadly in-line with the prior year.

On 22 January 2014 the Group announced that it had received acceptances from approximately 95% of the shareholders of Andor plc and that the offer was wholly unconditional from that date. Andor is a UK based high-technology company specialising in the manufacture of high-end scientific cameras, microscope systems and analytical software for the materials and life science industries. Andor's technology will extend our capability into the optical domain, which is the primary technology used for analysing biological samples at the nano scale, consistent with our recently announced strategy to expand into Nano-Bio.

The £175 million acquisition of Andor was funded from existing cash resources, a new £100 million revolving facility and a £60 million term facility. Both debt facilities are from a banking club comprising HSBC, Santander and RBS.

On 12 November 2013 the Group announced the acquisition of RMG Technology (RMG), completed on 8 November 2013. RMG is a young UK technology company which brings a unique laser technology to our Industrial Analysis business. Progress with integrating the business is on plan and we are seeing considerable interest from our Industrial Analysis customers.

On 21 December 2013, the Group acquired Roentgenanalytik Systeme, a small company based near Frankfurt, Germany, supplying X-ray analysis instrumentation to industrial markets. The acquisition will broaden Industrial Analysis' product range and give Roentgenanalytik access to global markets and increase investment in product development.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Rory King

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company with over 2300 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDDRXBBGSD
Date   Source Headline
2nd Jan 201911:33 amPRNHolding(s) in Company
17th Dec 20181:22 pmPRNHolding(s) in Company
12th Dec 201810:25 amPRNDirector/PDMR Shareholding
11th Dec 20185:07 pmPRNHolding(s) in Company
10th Dec 20189:34 amPRNHolding(s) in Company
3rd Dec 20183:20 pmPRNHolding(s) in Company
28th Nov 20189:31 amPRNHolding(s) in Company
26th Nov 201810:17 amPRNAppointment of Chairman
22nd Nov 201810:26 amPRNHolding(s) in Company
13th Nov 20189:49 amPRNDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
11th Oct 201810:38 amPRNDirector/PDMR Shareholding
11th Sep 20184:07 pmPRNResult of AGM
11th Sep 20181:47 pmPRNDirector/PDMR Shareholding
11th Sep 20187:00 amRNSInterim Chairman's AGM Statement 2018
13th Aug 20183:27 pmPRNDirector/PDMR Shareholding
24th Jul 201812:00 pmPRNHolding(s) in Company
23rd Jul 20181:00 pmRNSDeath of Chairman
19th Jul 20187:00 amPRNHolding(s) in Company
11th Jul 201812:15 pmPRNHolding(s) in Company
11th Jul 201811:51 amPRNDirector/PDMR Shareholding
5th Jul 201811:09 amPRNBlocklisting - Interim Review
4th Jul 201812:02 pmPRNDirector/PDMR Shareholding
12th Jun 201810:46 amPRNDirector/PDMR Shareholding
12th Jun 20187:00 amRNSFinal Results
11th May 201812:07 pmPRNDirector/PDMR Shareholding
11th Apr 20187:00 amRNSTrading Update
9th Apr 201811:03 amPRNDirector/PDMR Shareholding
1st Mar 201812:35 pmPRNDirector/PDMR Shareholding
8th Feb 20189:36 amPRNDirector/PDMR Shareholding
1st Feb 201811:21 amPRNTotal Voting Rights
9th Jan 20189:59 amPRNBlocklisting - Interim Review
5th Dec 201710:43 amPRNTotal Voting Rights
16th Nov 20179:22 amPRNHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
31st Oct 201710:02 amPRNDirectorate Change
3rd Oct 201711:42 amPRNTotal Voting Rights
26th Sep 20172:02 pmPRNCorrection : Director/PDMR Shareholding
26th Sep 201710:57 amPRNDirector/PDMR Shareholding
12th Sep 201711:59 amPRNResult of AGM
12th Sep 20177:00 amRNSAGM Statement
4th Sep 201711:14 amPRNTotal Voting Rights
17th Aug 201710:26 amPRNHolding(s) in Company
8th Aug 201712:55 pmPRNTotal Voting Rights
4th Jul 201710:24 amPRNBlocklisting - Interim Review
4th Jul 201710:12 amPRNTotal Voting Rights
3rd Jul 20172:48 pmRNSCompletion of Sale of Industrial Analysis to HHT
13th Jun 20178:41 amRNSAppointment of Senior Independent Director
13th Jun 20177:03 amRNSAppointment of Senior Independent Director
13th Jun 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.